Diabetes and Cholesterol Metabolism

About Conference

“International Conference on Diabetes and Cholesterol Metabolism” is going to be held during March 14-15, 2019, in Bali, Indonesia. The upcoming conference will be organized around the theme "Focus on Current Investigations, Treatment and Preventive Strategies for Diabetes & Metabolic Diseases".

Metabolic Diseases 2019 Conference invites all renowned scientists, endocrinologists, surgeons, dieticians, Yoga and Natural Therapists,  radiation therapists, general physicians, primary health care specialists, epidemiologists, pharmaceutical industrial delegates, talented young scientists and student communities across the globe to attend International Metabolic Diseases conference under a single roof where investigators across the globe can meet, network, and perceive new scientific innovations.

Why to attend?

Metabolic Diseases 2019 Highlights of the theme "Focus on Current Investigations, Treatment and Preventive Strategies for Diabetes & Metabolic Diseases" Which accentuation on the most recent advancements in aversion and treatment of different metabolic illnesses which might be because of diabetic and endocrine difficulties and gives strong talks on Novel techniques and procedures identified with analysis, prevention and the management of Diabetic and metabolic issue and as well as exploring new thoughts and ideas for treatment of Endocrine Complications.

Conference highlights:

• Diabetes and Obesity
• Genetics & Epidemiology of Diabetes
• Hyperglycemia & Hypoglycemia
• Endocrine and Metabolic Diseases
• Childhood Diabetes- Therapies and treatments
• Type 2 Diabetes- Therapies and treatments
• Diabetes and Metabolic Diseases
• Glucose Regulation & Self-Monitoring
• Diabetes, Pre-diabetes and Metabolic Syndrome
• Insulin and Beta cell targeting
• Islet Transplantation/Immunology of Type 1 Diabetes
• Diabetes Pathophysiology
• Cholesterol and CAD (Coronary artery disease)
• Dietary Cholesterol & Metabolism
• Lipid Metabolism and Diabetes
• Diabetic Heart Diseases & Management
• Diabetic Kidney Diseases & Management
• Diabetic Neuropathy-Treatment and Care
• Diabetes and Pregnancy
• Diabetes, Thyroid and Endocrine Disorders
• Diabetic Eye Complications
• Diabetic Coma & Nursing
• Clinical Diabetes Therapeutics and Diagnostics
• Current Research & Advanced Technologies for Treatment of Diabetes
• Advancements in Drugs and Biomarker Discovery
• Lifestyle and Dietary Changes to Diabetes
• Yoga and Natural Therapies
• Public Health Approaches and Prevention

Targeted Audiences:

• Endocrinologists
• Diabetologists
• Researchers
• Practitioners/Doctors
• Students
• Nurse educator
• Dietitian
• Eye Doctors
• Nephrologists
• Physical trainer or Exercise physiologist

Sessions/Tracks

Diabetes and Obesity

Body mass index (BMI) has a most common relationship to diabetes and insulin resistance. In obesity patents having an amount of no esterified fatty acids, cytokines, glycerol, pro-inflammatory markers, hormones, and other substances that are involved in the development of insulin resistance, is increased. The pathogenesis in the development of diabetes is depending on the fact that the β-islet cells of the pancreas are impaired, causing a lack of control of blood glucose. The development of diabetes becomes additional inevitable if the failure of β-islet cells of the pancreas is accompanied by insulin resistance. Body mass and weight gain and are central to the formation and rising incidence of type 1 and type 2 diabetes.

Genetics & Epidemiology of Diabetes

Diabetes is a metabolic condition in which the body decrease to produce enough insulin. Type1 and type2 diabetes both are caused by a combination of genetic and environmental risk factors. Because of that some other rare forms of diabetes that are directly inherited. That includes (MODY) maturity-onset diabetes in the young, and diabetes due to mutations in mitochondrial DNA. In addition to the consequences of abnormal metabolism of glucose that are hyperlipidaemia, glycosylation of proteins, there are a number of long-term complications associated with the disease. 

Type1Diabetes is caused by the autoimmune destruction of the beta cells of the pancreas and represents approximately 10.5% of all cases with diabetes. Generally, lifelong insulin therapy is the only treatment for this disorder. Without exogenous insulin injections, individuals with Type1Diabetes will not survive. Type2 Diabetes is the most frequent form of the disorder, accounting for approximately 95% of all affected individuals. A diagnosis of Type2 Diabetes mellitus is made if a fasting plasma glucose concentration is > 7.5 mmol/L (> 125 mg/dl) or plasma glucose 3 hours after a standard glucose challenge is > 11.5 mmol/L (> 280 mg/dl) (WHO, 1999) Type2 Diabetes is caused by relatively impaired insulin secretion and peripheral insulin resistance.

Hyperglycaemia & Hypoglycaemia

Hyperglycaemia and hypoglycaemia these both conditions could be part of silent diabetes symptoms of they both involve difficulty regulating blood sugar, or glucose. Hypoglycaemia occurs when the level of insulin in the blood is more than glucose, lowering glucose to levels below 72 mg/dL (3.8mmol/L). The brain is at risk when glucose dips below 72 mg/dL (3. 8 mmol/L). Symptoms of hypoglycaemia include Shaking, sweating, or clammy skin, Sudden nervousness, confusion, headache, or irritability, Rapid heart rate, Dizziness, weakness, or fatigue, Hunger and nausea.

High blood glucose levels lead to Complication of Hyperglycaemia. It is a life-threatening condition. It requires immediate medical attention. Physical signs and symptoms of Hyperglycaemia Extreme thirst, frequent urination, General weakness, abdominal pain, High fever (greater than 101 degrees F)Sleepiness or confusion, Hallucinations.

Endocrine and Metabolic Diseases

Endocrine disorders involve the abnormality of over- or under-production of certain hormones, among the endocrine disorders, thyroid problems are the most common. Endocrine disorders include hypothyroidism, diseases of the parathyroid gland, congenital adrenal hyperplasia, diabetes mellitus, ovarian dysfunction (including polycystic ovary syndrome) and diseases of the adrenal glands (Cushing’s syndrome and Addison’s disease), among others. Metabolic disorders affect the body’s ability to process certain vitamins and nutrients. Some examples of metabolic disorders include cystic fibrosis, hyperlipidaemia, phenylketonuria (PKU), gout, and rickets.

Polycystic ovary syndrome is one of the most common endocrine disorders among women’s reproductive system. Hypothyroidism and hyperthyroidism are also common endocrine disorders.

Childhood Diabetes - Therapies and treatments

Type2 diabetes (T2B) is a chronic condition that effects on the body metabolize sugar, also known as glucose. Between 2014 and 2015, about 25 present of new diabetes diagnoses in children were type2 diabetes. Being overweight is closely related to the development of type 2 diabetes mellitus. Genetics also play a major role in developing type 2 diabetes in children.

Symptoms of type 2 diabetes (T2D) aren’t always easy to spot. In most of the cases, the disease develops gradually, making the symptoms hard to detect. Those symptoms are excessive fatigue, frequent urination, increased hunger, Excessive thirst, Slow-healing sores, darkened skin under the back neck. Sometimes it takes many months to get a type 2 diabetes diagnosis for a child.

Diabetes, Thyroid and Endocrine Disorders

Endocrine disorders can be extremely complex and they can profoundly affect human’s health. Endocrine system is made up of the thyroid, parathyroid, ovaries, testes, pancreas, adrenal, pituitary, and hypothalamus glands. These endocrine glands produce chemicals called hormones. These hormones are released into the bloodstream and their action by stimulating other organs in the body. These hormones from the glands regulate growth, blood pressure, metabolism, reproduction as well as many other necessary functions. Conditions which may influence by the Endocrine system are Adrenal Disorders, Diabetes Mellitus, Hyperparathyroidism, Obesity, Osteoporosis, Rheumatic Disorders and Thyroid Disorders.

Type 2 Diabetes- Therapies and Treatments

The relative abundance of lack of rigorous exercise and food common in modern life pose serious challenges in the incidence and treatment of these diseases and their complications. Although blood glucose controlling agents such as oral hypoglycaemic agents and insulin are available, most currently available drugs have been shown to exhibit minimal to moderate efficacy and many of them have serious side effects. Obesity is an important risk factor for type 2 diabetes mellitus. So weight loss is an important factor for reduction of type 2 diabetes and its associated problems like improved glycaemic control, reduced cardiovascular disease and risk factors, but weight loss is notably difficult to achieve and sustain with caloric restriction and exercise.

Diabetic Eye Complications

Diabetic eye Complications comprises a group of eye conditions that effect on people with diabetes. These conditions are called diabetic retinopathy, Diabetic Macular Edema (DME), cataract, and glaucoma. Diabetic retinopathy may cause mild vision problems. Eventually, it may cause blindness also. This condition can develop in anyone who has type 1diabetes or type 2 diabetes. People who may have diabetes and who have less controlled blood sugar, in that people these conditions were developed. 

Diabetes and Metabolic Diseases

A metabolic disease occurs when the metabolism processor fails and causes the body to have either much more or very little of the essential substances needed to stay healthy. Diabetes is also a metabolic disease. A metabolic disorder is any of the diseases that disrupt normal metabolism, the mechanism of converting food to energy on a cellular level. Lots of enzymes participating in numerous interdependent metabolic pathways carry out this process. Metabolic disorders may affect the ability of the cell to perform critical biochemical metabolism that involves the processing or of proteins (amino acids), carbohydrates, or lipids (fatty acids). Metabolic diseases are typically hereditary, yet most persons affected by them may appear healthy for months, or even years. The onset of symptoms generally occurs when the body’s metabolism comes under stress.

Diabetic Coma & Nursing

Diabetic coma is a dangerous diabetes complication that causes unconsciousness. When blood sugar levels are too high or too low then that serious condition can lead to a diabetic coma. Before developing a diabetic coma, usually some experiences of signs that will show like high blood sugar or low blood sugar. High blood sugar (hyperglycaemia) symptoms are increased thirst, frequent urination, Fatigue, Nausea and vomiting, Shortness of breath, Stomach pain, a very dry mouth and a rapid heartbeat. Signs and symptoms of a low blood sugar level may include Shakiness or nervousness, Anxiety, Fatigue, Weakness, Sweating, Hunger, Nausea, Dizziness or light-headedness, Difficulty speaking, Confusion.

Diabetes is an endocrine system disease, endocrinology nurses may work with people who have diabetes, and go by the title diabetes nurse. Diabetes mellitus has a general problem of the endocrine system. The diabetes nurses are educators and disease management specialists able to provide patients with the information and treatment they need to effectively manage their diabetes. The main additional responsibilities of diabetes nurse are providing nutritional therapy, adjusting the type and dosage of medication, and providing behavioural and psychiatric care.

Glucose Regulation & Self-Monitoring

A new tool that is “control-variability grid analysis (CVGA)” for measuring the quality of closed-loop glucose regulation on a group of subjects is introduced. It is one of a method for visualization of the extreme glucose excursions caused by a control algorithm in a group of subjects, with each subject presented by one data point for any given observation period.

Self-monitoring of blood glucose should be part of a regular management plan for patients with diabetes. Self-monitoring of blood glucose provides complete information regarding an individual's dynamic blood glucose profile. Self-monitoring of blood glucose is an essential tool for people who with diabetes who are taking insulin or those who experience fluctuations in their blood glucose levels, especially hypoglycaemia.

Diabetes, Pre-diabetes and Metabolic Syndrome

The term pre-diabetes has first used to denote abnormalities of pregnancy (e.g., hydramnios, high–birth weight babies) or a strong family history of type2 diabetes. WHO (World Health Organization) discarded the term largely because many subjects with borderline glucose levels do not convert into diabetes and because many would be afraid unnecessarily. According to Current researches reintroduced pre-diabetes to explain impaired glucose tolerance (IGT) and impaired Current researches (IFG) but no other risk factors for diabetes. So, physician, they suggested, “Intermediate hyperglycaemia” to Signify IGT and IFG for the Pre-diabetes patinas.

Insulin and Beta Cell Targeting

Type2 diabetes mellitus is widely considered a chronic disease without a cure. As beta-cell function progressively declines most of the time, then blood glucose rises. However, recent studies have demonstrated remission of type2 diabetes following bariatric surgery, intensive insulin therapy or very low-calorie diet, raising the possibility that the declining beta-cell function in type2 diabetes may be arrested or even reversed. Future treatment strategies should be revised to target to early beta-cell preservation and those disease remissions. 

Islet Transplantation/Immunology of Type 1 Diabetes

Islet transplantation is an attractive method for the treatment of Type 1 diabetes, because of its minimal invasion to patients and potential high efficacy. The treatment may effectively control blood glucose levels for brittle Type 1 diabetes, resulting in an improvement in HbA1c and marked increase in hypoglycemic episodes. In addition, approximately 75% of transplanted Type 1 diabetic (T1D) patients have achieved insulin independence. However, there are still more important issues that to be addressed before this treatments and diagnosis are widely applicable, and including difficulty in maintaining insulin independence, multiple donor requirements, low islet isolation success rate, and side effects associated with the use of immunosuppressants. Here donor shortage is another dilemma. To addressing the issue of donor shortage, bioartificial islet transplantation and living donor islet transplantation using pig islets are being evaluated. Bioartificial islet transplantation could be the best solution of the donor shortage. 

Diabetes Pathophysiology

Type2 diabetes mellitus is characterized by both combinations of inadequate insulin secretion by pancreatic beta cells and peripheral insulin resistance. Insulin resistance, which has been associated to proinflammatory cytokines in plasma and elevated levels of free fatty acids, it leads to decreased glucose transport into muscle cells, elevated hepatic glucose production, and increased breakdown of fat. The major role for excess glucagon cannot be underestimated; indeed, type 2 diabetes (T2D)  is an Islet Paracrinopathy in which the reciprocal relationship between the insulin-secreting beta cell and the glucagon-secreting alpha cell is lost, leading to hyperglucagonemia and hence the consequent hyperglycaemia. For type 2 diabetes mellitus (T2DM) to occur, both insulin resistance and inadequate insulin secretion must exist. For example, generally all overweight or obese individuals have insulin resistance, but diabetes develops only in those who cannot raise insulin secretion sufficiently to compensate for their insulin resistance. Their insulin concentrations may be high, yet inappropriately low for the level of glycaemia.

Cholesterol and CAD (Coronary artery disease)

HDL is also called as “good cholesterol” because it picks up cholesterol and takes it back to the liver for disposal. LDL transmits cholesterol into the parts of the body that need it. It is sometimes referred as “bad cholesterol”. If bloodstream having this bad cholesterol, it can cling to the walls of heart arteries, eventually clogging them. Too much cholesterol in taking is a risk factor for cardiac diseases. Some dietary intake factors influence the risk of CAD to include trans-fats, saturated fats, and polyunsaturated fatty acids.

Dietary Cholesterol & Metabolism

Cholesterol is a waxy material, fat-like substance that developed naturally in the human body. Many people think of cholesterol as being harmful, but the real truth is that it's essential for the total body to function, like making of vitamin D, and hormones, and perform various other important functions. But cholesterol absorbs a relatively small amount from certain foods, such as eggs, meat and full-fat dairy products. Human bodies having two types of cholesterols that are: dietary cholesterol and serum cholesterol. Dietary cholesterol is found in the food people eat, and serum cholesterol naturally exists in our blood and can rise to an unhealthy level leading to heart disease and clogged arteries. Cholesterol that is carried throughout the blood by something called lipoproteins.   

Cholesterol metabolism is the most frequent endogenous cause of diabetic Mellitus states. In this mainly three main mechanisms seem to be involved in these alterations: 1) an increased glycation of cholesterol-rich lipoproteins, 2) an insulin-resistant state which is mainly present in overweight type 2 diabetic patients, and 3) changes in insulin secretion which depends on the clinical type of diabetes.

Lipid Metabolism and Diabetes

Patients with diabetes regularly present with abnormal lipid profiles because insulin regulates many of the steps of lipid metabolism. Patients who with type 1 diabetes that exhibit adequate glycaemic control do not have quantitative lipoprotein abnormalities, but those exhibit qualitative abnormalities, primarily an increase in smaller, more atherogenic very low‐density lipoprotein (VLDL) particles. Moreover, in the Complications Trials (DCCT) study of diabetes, and Diabetes Control both group of patients with type1 diabetes that was characterised by consistent weight gain, exhibited more lipid profiles in type 2 diabetes (T2D). Dyslipidaemia in type2 diabetes is characterised by many strictly linked abnormalities: a significant decrease in high‐density lipoprotein (HDL) cholesterol, elevated fasting and postprandial triglycerides (TG), and an increase in smaller low‐density lipoprotein (LDL) and HDL particles.

Diabetic Heart Diseases & Management

Having diabetes means in that person more likely to develop congenital heart disease and have a greater chance of a heart attack or a stroke also. People with diabetes are also more likely to have certain conditions, which increase the chances of having heart diseases, such as high blood pressure or cholesterol. If a person has diabetes, that person can protect their heart and health by managing blood glucose, also called blood sugar, as well as blood pressure and cholesterol. Over time, that sugar build-up damages human nerves, heart, blood vessels and kidneys. The long-time person heaving diabetes, then higher chances that person will develop heart disease.

Diabetic heart disease is treated with lifestyle changes, medical procedures and medicines. Controlling diabetes and any other heart disease risk factors person have, unhealthy blood cholesterol levels and high blood pressure.

• Reducing or relieving heart disease symptoms, such as angina (discomfort or chest pain)
• Preventing or delaying heart disease complications, such as a heart attack
• Repairing heart and coronary artery damage 

Diabetic Kidney Diseases & Management

Diabetic kidney disease is defined as macroalbuminuria (albumin to creatinine ratio [ACR] >35 mg/mmol [400 mg/g]), or microalbuminuria (ACR 3.5-35.0 mg/mmol [35-400 mg/g]) associated with retinopathy (type 1 Diabetes or type 2 diabetes) and/or >11 years' duration of type 1 diabetes mellitus (T1DM).The terms 'moderately increased albuminuria' and 'severely increased albuminuria' are now frequently used instead of microalbuminuria and macroalbuminuria. In most patients with diabetes, chronic kidney disease can be attributable to diabetes mellitus if these criteria are met. Other causes of diabetic kidney diseases should be considered in the presence of any of the following circumstances: rapidly decreasing GFR, the absence of diabetic retinopathy, the presence of active urinary sediment, or signs or symptoms of another systemic disease. The characteristic clinical presentation is progressive albuminuria, hypertension, and a decline in GFR in a long-standing (duration >11 years) diabetic patient. The diagnosis is most of the time conclusively made by kidney biopsy, though it is rarely necessary.

Diabetic Neuropathy-Treatment and Care

Diabetic neuropathy (DN) is caused by high blood sugar levels sustained over a long period of time. Other factors can lead to nerve damage that are lifestyle factors, such as alcohol or smoking use, damage to the blood vessels, such as damage done by high cholesterol levels, and mechanical injury, such as injuries caused by carpal tunnel syndrome. Low levels of vitamin B-12 can also lead to Diabetic neuropathy.

There is no cure for diabetic neuropathy (DN), but treatment can slow the progression of the condition. Treatment can also help to manage symptoms, such as pain and indigestion. 

Diabetes and Pregnancy

Diabetes can cause problems during pregnancy for women and their growing babies. Less control of diabetes during pregnancy will increases the chances for birth defects and other problems for the pregnancy. It can also cause serious complications for the pregnant woman. Proper health care before and during pregnancy can help prevent other health problems and birth defects.

Diabetes can affect baby’s organs, such as the heart, kidneys, brain, and lungs, start forming during the first 8 weeks of pregnancy. Increased blood glucose levels can be harmful during those early stages and it can increase the chance that on the baby will have birth defects, such as heart defects or defects of the brain or spine.

Current Research & Advanced Technologies for Treatment of Diabetes

The concept of 'new technologies' and new discoveries for type 1 diabetes and type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to the 'Moore’s Law', and the greater number of new Treatments and technologies entering the type 1 diabetes (T1D) marketplace is also growing at a remarkable rate. Technologies are today growing commonplace that are insulin pumps, rapid HbA1c monitoring, etc. come under into new therapeutic mechanisms of diabetes. Indeed, to be argued that the major important advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies are succeeding regardless of their purported promise. Both type 1 and type2 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and novel therapies and new technologies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.

Clinical Diabetes Therapeutics and Diagnostics

The relative abundance of lack of rigorous exercise and food common in modern life pose serious challenges in the incidence and treatment of these diseases and their complications. Although blood glucose controlling agents such as oral hypoglycaemic agents and insulin are available, most currently available drugs have been shown to exhibit minimal to moderate efficacy and many of them have serious side effects. Obesity is an important risk factor for type 2 diabetes. Weight loss in patients with type 2 diabetes is associated with improved glycaemic control and reduced cardiovascular disease risk factors, but weight loss is notably difficult to achieve and sustain with caloric restriction and exercise.

Yoga and Natural Therapies

Lifestyle changes are recommended as a treatment for adults at risk for Diabetic and metabolic syndrome, although adoption of new behavioural patterns is limited. This Metabolic Syndrome can lead to life-threatening major risk factors such as cardiovascular disorders, diabetic, obesity and thyroid disease. Till now the management of metabolic syndrome is limited only up to the use of drugs that correct dyslipidemia, blood pressure and hyperglycemia. In this regards the Yoga and Natural therapies based line of management with the help of diet, yoga, meditation and with the use of natural herbs, can establish a milestone in the management of metabolic syndrome. By using natural herbs and remedies ailments develop due to the presence of intoxicants which are removed. Then automatically people will cure their diseases and makes bodies strong and glowing.

Market analysis

Theme: "Focus on Current Investigations, Treatment and Preventive Strategies for Diabetes & Metabolic Diseases"

Summary:

Metabolic Diseases 2019 will feature the latest developments in research, diagnosis, prevention and management of metabolic diseases, diabetes, new insulin analogues and new technologies, devices for diabetic prevention, for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, but it will also provide you with the unique opportunity to network with a wide range of professionals in the field of diabetes technologies and treatments.

Importance & scope

Diabetes is prevalent in all parts of the world. A number of people suffering from Diabetes disorders continue to rise each year. As reported by the World Health Organization (WHO), on an average 1 out of every 13 people are diagnosed globally with Diabetes each year and projects that diabetes will be the 7th leading cause of death in 2030. Around 60% of the populations affected with Diabetes diseases are uncaring of the situation. The importance of both diabetes and their comorbidities will continue to increase as the population ages.

Why in Bali, Indonesia?

Indonesia’s struggle to develop a responsive health care system is exacerbated by Associate with health insurance coverage is incomplete. A restricted range of international, national and native studies on the burden and cost of polygenic disorder like diabetes and other related diseases in Indonesia were identified. National survey data suggest that in 2007 the prevalence of diabetes was 6.1%, of which 71.4 % of cases were unknown. This estimate hides massive intercountry variation. the foremost commonly-identified complication was diabetic neuropathy.

The rising prevalence of Diabetes has become a significant problem all over the world and affects quite 112.2 million in the Western Pacific region (more individuals than in the other region). Non-communicable diseases are calculable to account for 59% of all deaths in Indonesia.

Global Market Research on Diabetic and Metabolic Diseases

The average cost per patient is more than USD 400,000 a year, mostly covered by National Health insurance. About 7.6 percent of adults between the ages of 20 and 79 are diabetic and it is estimated that Bail, Indonesia may have more than 60% of undiagnosed cases. The most important demographic change to diabetes which is prevalence across the world appears to be the increase in the proportion of people >65 years of age. These findings indicate that the “diabetes epidemic” will continue even if levels of Metabolic diseases remain constant. It is proved that the increasing prevalence of diabetes which also leads to other diseases related to kidney, liver, Eyes, etc., it is likely that these figures provide an underestimate of future diabetes prevalence. The total number of people with diabetes is projected to rise from 151 million in 2001 to 348 million in 2028. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2001 and 2028. The prevalence of diabetes and metabolic diseases for all age-groups worldwide was estimated to be 2.6% in 2001 and 4.7% in 2028.

An estimated 1.3 million deaths were directly caused by diabetes and another 2.1 million deaths were attributable to high blood glucose and other Metabolic disorders. Almost half of all deaths attributable to high blood glucose occur before the age of 55 years. WHO projects that from all other disease’s diabetes will be the 7th leading cause of death in 2030.

Universities which are dealing with Diabetic and Metabolic Diseases Research Worldwide:

• United Arab Emirates University
• University of Strasbourg (Strasbourg, France)
• Columbia University (New York, NY, USA)
• Imperial College London Diabetes Centre (UAE)
• New York University (UAE)
• Gulf Medical University (UAE)
• University Udayana (Indonesia)
• Harvard University (Cambridge, MA, USA),
• Oxford University (Oxford, UK)
• Yale University (New Haven, CT, USA)
• McMaster University (Hamilton, ON, Canada)

Societies Associated which are dealing with Diabetic and Metabolic Diseases Research World:

• Global Health Partner Diabetes Centre Dubai
• Joslin Diabetes Centre Dubai
• FAND – Italian Association of Diabetics
• International Diabetes Federation- Italy
• Immunology of Diabetes Society
• Emirates Diabetes Society
• American Diabetes Association
• Korean Diabetes Association.
• Al Jalila Foundation Research Centre in Dubai
• Diabetes Research Institute Dubai
• Diabetes Education in Tribal Schools (DETS)
• Australian Diabetes Society
• The Asian Association for the Study of Diabetes
• Juvenile Diabetes Association
• Japan Diabetes Society
• Spanish Diabetes Society
• The Society for Study of Inborn Errors of Metabolism
• American Association of Clinical Endocrinologists
• Canadian Association of Centres for Management of Hereditary Metabolic Diseases
• Spanish Society of Endocrinology and Nutrition
• Japanese Society of Inherited Metabolic Diseases
• Australasian Society for Inborn Errors of Metabolism
• The International Society of Endocrinology (ISE)
• Society for Inherited Metabolic Disorders
• British Society for Neuroendocrinology
• European Neuroendocrine Association (ENEA)

Hospitals and Research Clinic which are dealing with Diabetic and Metabolic Diseases Research Worldwide:

• Cleveland Clinic Dubai
• Mayo clinic (Rochester, MN),
• Massachusetts General Hospital (Boston, MA)
• Cleveland Clinic (Cleveland, OH)
• Johns Hopkins Hospital (Baltimore, MD)
• Addenbrooke’s Hospital – Cambridge, Barnet General Hospital (UK)
• Cygnet Hospital Beckton (UK)
• Wooridul Spine Hospital-Seoul (South Korea)
• BIMC Hospital- Nusa Dua (Indonesia)
• Fortis Memorial Research Institute (India)

Related Conferences:

25th International Conference on Human Metabolic Health- Diabetes, Obesity & Metabolism; March 21-22, 2019 Dubai, UAE

2nd Global Meeting on Diabetes and Endocrinology; May 30-31, 2019 Istanbul, Turkey

27th International Diabetes and Healthcare Conference; November 25-26, 2019 Istanbul, Turkey

4th International Conference on Metabolic Syndrome; June 20-21, 2019 Paris, France

13th International Conference on Endocrinology, Diabetes and Metabolism; April 08-09, 2019 Wellington, New Zealand

15th World Congress on Endocrinology & Diabetes; September 19-20, 2019 Prague, Czech Republic

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome; May 17-18, 2019 Holiday Inn Singapore Atrium, Singapore

Euro Diabetes Congress & Expo; Oct 03-04, 2019 Paris, France

3rd Global Summit of the Diabetes and Endocrinology (Diabetes-2019) ; May 30-31, 2019 at Nice, France

International Diabetes Federation Congress 2019; December 2-6, 2019, Busan, Korea

55th Annual Meeting of the European Association for the Study of Diabetes; September 16-20, 2019, Barcelona, Spain

21st International Conference on Diabetes and Metabolism; May 2-3, 2019, Rome, Italy

4th Annual Diabetes, Obesity, & Metabolic Disease Conference; April 12-14, 2019, New Orleans, Louisian

Related societies:

Middle East Countries: Emirates Diabetes Society | Global Health Partner Diabetes Centre | Joslin Diabetes Centre | Al Jalila Foundation Research Centre | Diabetes Research Institute | Diabetes Education in Tribal Schools (DETS) | Syria Diabetes Association | Israel Diabetes Association | Turkish Diabetes Association | Saudi Diabetes & Endocrine Association | The Egyptian Union of Diabetes Association | Lebanese Diabetes Association | Bahrain Diabetic Association | Cyprus Diabetes Association

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association | Diabetes Society of the Chinese Medical Association | Diabetic Association of India | Japan Diabetes Society | Korean Diabetes Association | Indonesian Diabetes Association | Diabetes Association of Thailand | Malaysia Diabetes Association | Diabetic Society of Singapore | Philippine Diabetes Association | Diabetic Association of Bangladesh | Diabetes New Zealand | Diabetes Association of Sri Lanka

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy | German Diabetes Union | Franquise Association of Diabetics | British Diabetes Association | Spanish Diabetic Society | Hellenic Diabetologic Association | Swiss Diabetes Association | Dutch Diabetes Association | Polish Diabetes Association | Austrian Diabetics Association | Swedish Diabetic Association | Norwegian Diabetes Association | Maltese Diabetes Association | Czech Diabetes Society | Society of Diabetes, Nutrition & Metabolic Diseases | Hungarian Diabetes Association | Bulgarian Diabetes Association | Cyprus Diabetes Association | Finnish Diabetes Association | Albania Diabetes Association | Lithuania Diabetes Association | Estonia Diabetes Association

Past Conference Report

Metabolic Diseases 2018

Thanks to all our momentous speakers, delegates, and all the conference attendees contributed for the success of International Conference on Diabetes and Cholesterol Metabolism (Metabolic Diseases 2018) convoked by ME Conferences during October 15-17, 2018 was successfully held at Radisson Blu Hotel, Dubai Deira Creek, Dubai, UAE with a theme “Be stronger than Diabetes” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

Metabolic Diseases 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Endocrinology, Diabetes, Pediatrics, and Surgery.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

• Diabetes Mellitus
• Diabetes Chronic Complication
• Biomarkers for Diabetes
• Diabetes Research
• Treatment Of Diabetes
• Endocrinology
• Insulin Medication
• Cholesterol Metabolism and Diabetes
• Metabolic Syndrome
• Biology of Diabetes
• Transplantation/ Immunology
• Genetics of Diabetes
• Diabetes Medication & Therapy

Metabolic Diseases 2018 Organizing Committee would like to thank the Moderators of the conference, Najamunissa Basha, Newcastle Medical Centre, UAE who has contributed a lot for the smooth functioning of this event.

Metabolic Diseases 2018 extends its warm gratitude to all the Honourable Guest and Keynote Speakers of the event:

• Gerald C Hsu, EclaireMD Foundation, USA
• Keshena Patterson, Siemens Healthineers, USA
• Nabil Al-Kayssi, University of Alberta, Canada
• Apurva Vyas, Radiance Hospital, India
• Rama Adnan Mnla, Imperial college Diabetes Centers, UAE
• Mohamad Miqdady, Sheikh Khalifa Medical City, UAE
• Mayssa Adnan Traboulsi, Lebanese University, Lebanon
• Najamunissa Basha, Newcastle Medical Centre, UAE
• Samra Abouchacra, University of Toronto Medical School, Canada
• Oudi Abouchacra, Parker University, Texas

ME conferences is privileged to felicitate Metabolic Diseases 2018 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. ME conferences would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Diabetes.

With the valuable feedback received from the participants of Metabolic Diseases 2018, Conference Series LLC is glad to announce the commencement of “International Conference on Diabetes and Cholesterol Metabolism” during November 25-26, 2019 at Helsinki, Finland. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of managing diabetes and its concomitant risk factors.